Drugs for Migraine with Aura (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 138)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Milnacipran |
Approved, Investigational |
Phase 4 |
|
92623-85-3, 96847-54-0 |
11622909 65833 6917779 |
Synonyms:
(-)-Milnacipran
(+-)-Milnacipran
(1S,2R)-MILNACIPRAN
1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCL
1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCL
F 2207
F 2695
F2207
F-2695
F-2695|Fetzima®
Fetzima
|
Ixel
Levomilnacipran
Midalcipran
Milnacipran
Milnacipran hydrochloride
Milnacipranum
Milnacipranum [latin]
Savella
Savella®
Toledomin
|
|
2 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
3 |
|
Topiramate |
Approved |
Phase 4 |
|
97240-79-4 |
5284627 |
Synonyms:
[(1R,2S,6S,9R)-4,4,11,11-TETRAMETHYL-3,5,7,10,12-PENTAOXATRICYCLO[7.3.0.0^{2,6}]DODECAN-6-YL]METHYL SULFAMATE
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
|
Epitomax
epitomax|Eprontia® (liquid formulation)|MCN-4853|RWJ-17021|Topamax®
MCN-4853
QUDEXY XR
RWJ-17021
RWJ-17021-000
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
Topamax
Topamax sprinkle
TOPIRAMATE
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
TPM
Trokendi XR
USL255
USL-255
|
|
4 |
|
Metoclopramide |
Approved, Investigational |
Phase 4 |
|
364-62-5 |
4168 |
Synonyms:
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
4-Amino-5-chloro-2-methoxy-N-(b-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(β-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-O-anisamide
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXYBENZAMIDE
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
4-AZANYL-5-CHLORANYL-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
Apo-Metoclop
Berk brand OF metoclopramide hydrochloride
Cerucal
CLOPRA
CLOPRA-"YELLOW"
Clopra-Yellow
Clopromate
DEL
Dihydrochloride, metoclopramide
Duraclamid
Elieten
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
Gastro-Timelets
Gimoti® (metoclopramide nasal spray)|metaclopromide|methochlopramide|metochlopramide|metoclopramide hydrochloride|Reglan®
Hydrochloride, metoclopramide
Imperan
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
|
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
METOCLOPRAMIDE
Metoclopramide dihydrochloride
Metoclopramide Hcl
Metoclopramide hydrochloride
Metoclopramide Intensol
Metoclopramide monohydrochloride
Metoclopramide monohydrochloride, monohydrate
Metoclopramide Omega
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
Monohydrochloride, metoclopramide
Moriperan
Mygdalon
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Primperan
Reclomide
Reglan
Reliveran
Rimetin
Temmler brand OF metoclopramide hydrochloride
Terperan
|
|
5 |
|
Ketorolac |
Approved |
Phase 4 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
6 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
7 |
|
Almotriptan |
Approved, Investigational |
Phase 4 |
|
181183-52-8, 154323-57-6 |
123606 |
Synonyms:
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine
1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulphonyl)pyrrolidine
Almogran
Almogran®|Axert®|LAS-31416|PNU-180638E
Almotriptan
Almotriptan malate
|
ALMOTRIPTAN MALEATE
Axert
LAS-31416
LAS-31416 D,L-MALATE ACID
LAS-31416-D,L-MALATE-ACID
PNU-180638E
|
|
8 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
9 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
10 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
11 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
12 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
13 |
|
Antiemetics |
|
Phase 4 |
|
|
|
14 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
15 |
|
Ketorolac Tromethamine |
|
Phase 4 |
|
|
|
Synonyms:
ACULAR
ACULAR LS
ACULAR PRESERVATIVE FREE
ACUVAIL
|
KETOROLAC TROMETHAMINE
SPRIX
TORADOL
|
|
16 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
17 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
18 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
19 |
|
Caffeine |
Approved |
Phase 3 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
20 |
|
Eletriptan |
Approved, Investigational |
Phase 3 |
|
143322-58-1 |
77993 |
Synonyms:
(R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole
(R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide
3-(1-Methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide
ELETRIPTAN
Eletriptán
élétriptan
Eletriptan hydrobromide
Eletriptanum
|
Relpax
Relpax®|UK 116044
UK 116044
UK-116,044-04 FREE BASE
UK-116044
UK-116044-04
UK-116044-04 [AS HYDROBROMIDE)
UK-116044-04 FREE BASE
|
|
21 |
|
Rizatriptan |
Approved |
Phase 3 |
|
145202-66-0, 144034-80-0 |
5078 |
Synonyms:
L-705126
Maxalt
Maxalt®|MK-0462|MK-462|MK-A462|rizatriptan benzoate
MAXALT-MLT
MK 462 Free base
MK-0462
MK-462
MK-462 FREE BASE
MK-A462
|
N,N-Dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine
N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine
Risatriptan
RIZATRIPTAN
RIZATRIPTÁN
Rizatriptan benzoat
Rizatriptan benzoate
Rizatriptanum
|
|
22 |
|
Sumatriptan |
Approved, Investigational |
Phase 3 |
|
103628-46-2 |
5358 |
Synonyms:
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide
(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulphonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide
1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide
3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulphonamide
estradiol
Glaxo wellcome brand OF sumatriptan
GR-43175C
GR-43175C|Imigran®|Tosymra® (nasal spray)
GSK Brand OF sumatriptan
Imigran
Imigran recovery
|
Imitrex
Imitrex Oral
N02CC01
NP101
Succinate, sumatriptan
Sumatran
SUMATRIPTAN
SUMATRIPTÁN
Sumatriptan GSK brand
Sumatriptan succinate
Sumatriptanum
Sumatriptanum [INN-Latin]
Sumax
TOSYMRA
TRIPTAN
|
|
23 |
|
Angiotensin II |
Approved, Investigational |
Phase 2, Phase 3 |
|
68521-88-0, 11128-99-7, 4474-91-3 |
172198 |
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
Angiotonin
|
Asp-arg-val-tyr-ile-his-pro-phe
Delivert
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-Α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
24 |
|
Candesartan cilexetil |
Approved |
Phase 2, Phase 3 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
25 |
|
Propranolol |
Approved, Investigational |
Phase 2, Phase 3 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Î’-propranolol
|
|
26 |
|
Histamine |
Approved, Investigational |
Phase 3 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(3H-Imidazol-4-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
|
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Eramin
Ergamine
Ergotidine
Histamine
HSM
Imidazole-4-ethylamine
NSC-33792
Î’-imidazolyl-4-ethylamine
|
|
27 |
|
Diphenhydramine |
Approved, Investigational |
Phase 3 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
[2-(DIPHENYLMETHOXY)ETHYL]DIMETHYLAMINE
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
ANTITUSSIVE
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
BELDIN
BELIX
Benadryl
BENADRYL PRESERVATIVE FREE
Benadryl®|benzhydramine|dimehydrinate
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
CALADRYL
Citrate, diphenhydramine
COLTEX
DIBENIL
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
DIMEHYDRINATE
Dimethylamine benzhydryl ester
Diphamine
Diphantine
|
DIPHEN
DIPHENHYDRAMINE
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
DIPHENHYDRAMINE HCL
Diphenhydramine hydrochloride
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
DREEMON
DYTUSS
FEDRIL
GPPE COUGH EXPECT PAED
GPPE ORAL SOLN
HISTERGAN
HYDRAMINE
Hydrochloride, diphenhydramine
MEDINEX
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
NIGHTCALM
NSC-33299
NYTOL
NYTOL ONE-A-NIGHT
O-Benzhydryldimethylaminoethanol
PAXIDORM
Restamin
SILPHEN
SLEEPIA
SYNTEDRIL
TIXYLIX CATARRH
VICKS FORMULA 44
Α-(2-dimethylaminoethoxy)diphenylmethane
Î’-dimethylaminoethanol diphenylmethyl ether
Î’-dimethylaminoethyl benzhydryl ether
|
|
28 |
|
Promethazine |
Approved, Investigational |
Phase 3 |
|
60-87-7 |
4927 |
Synonyms:
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
Atosil
Diphergan
Diprazin
Hydrochloride, promethazine
Isopromethazine
Lilly 1516
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
NSC-30321
Phenargan
Phenergan
Phenergan®|Sominex®
Phensedyl
Pipolfen
Pipolphen
Proazaimine
Proazamine
|
Promazinamide
Promet
Prometazin
Prometazina
Prometazine
PROMETHACON
Promethazin
PROMETHAZINE
Promethazine hydrochloride
Promethazinum
PROMETHEGAN
Promethiazine
Promezathine
Prothazin
Prothazine
Pyrethia
Remsed
RP-3277
Rumergan
SOMINEX
ZIPAN-25
ZIPAN-50
|
|
29 |
|
Ketoprofen |
Approved, Vet_approved |
Phase 3 |
|
22071-15-4 |
3825 |
Synonyms:
19583RP
2-(3-Benzoylphenyl)propionate
2-(3-Benzoylphenyl)propionic acid
3-Benzoyl-alpha-methylbenzeneacetate
3-Benzoyl-alpha-methylbenzeneacetic acid
3-Benzoyl-a-methylbenzeneacetate
3-Benzoyl-a-methylbenzeneacetic acid
3-Benzoylhydratropate
3-Benzoylhydratropic acid
3-Benzoyl-α-methylbenzeneacetate
3-Benzoyl-α-methylbenzeneacetic acid
ACTRON
Actron®|Orudis®
Alrheumat
Alrheumum
Alrheumun
AXORID
Benzoylhydratropic acid
Capisten
Dexal
Epatec
Fastum
FENOKET 200
IDEA-033
Iso-K
JOMETHID XL
Kefenid
KETOCID 200
KETONAL
KETOPROFEN
Ketoprofeno
Ketopron
KETOTARD 200 XL
|
KETOVAIL
KETOZIP 200 XL
L'acide (benzoyl-3-phenyl)-2-propionique
LARAFEN
LARAFEN CR
Lertus
m-Benzoylhydratropate
m-Benzoylhydratropic acid
Menamin
Meprofen
NEXCEDE
Orudis
ORUDIS (TN)
ORUDIS 100
ORUDIS KT
Orugesic
ORUVAIL
ORUVAIL 100
ORUVAIL 150
ORUVAIL 200
ORUVAIL IM
Oscorel
POWERGEL
Profenid
R.P. 19583
RP-19583
RU-4733
TILOKET
TILOKET CR
Toprec
Toprek
VALKET 200 RETARD
|
|
30 |
|
Dopamine |
Approved |
Phase 3 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
31 |
|
Ergotamine |
Approved |
Phase 3 |
|
113-15-5 |
8223 |
Synonyms:
(5'a)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
(5'Α)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
12'-Hydroxy-2'-methyl-5'a-(phenylmethyl)ergotaman-3',6',18-trione
12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione
12'-Hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione
CAFERGOT
Cafergot®|Ergomar®
Cornutamine
Ergo kranit
Ergo sanol
Ergodryl mono
Ergo-kranit
ErgoKranit
Ergomar
Ergostat
|
Ergotamin
Ergotamina
ERGOTAMINE
Ergotamine tartrate
Ergotamine tartrate (2:1)
Ergotaminine
Ergotaminum
Gynergen
Krewel brand OF ergotamine tartrate
Lingraine
Lotus brand OF ergotamine tartrate
mono, Ergodryl
NSC-95090
Pfizer brand OF ergotamine tartrate
Sanofi winthrop brand OF ergotamine tartrate
Tartrate, ergotamine
|
|
32 |
|
Dihydroergotamine |
Approved, Investigational |
Phase 3 |
|
6190-39-2, 511-12-6 |
10531 |
Synonyms:
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.02,6]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.02,7.012,16]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE
5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
9,10-Dihydroergotamine
9,10-Dihydro-ergotamine
Agit
Aliud brand OF dihydroergotamine mesylate
Alpharma brand OF dihydroergotamine mesylate
Angionorm
Anto brand OF dihydroergotamine mesylate
Clavigrenin
CT Arzneimittel brand OF dihydroergotamine mesylate
CT-Arzneimittel brand OF dihydroergotamine mesylate
D Tamin retard l.u.t.
D.H.E. 45
D.H.E. 45®|Migranal®
Desitin brand OF dihydroergotamine mesylate
DET MS
DHE 45
DHE puren
DHE ratiopharm
DHE111
DHE45
DHE-45
DHE-puren
DHE-ratiopharm
DIERGO
Dihidroergotamina
Dihydergot
DIHYDROERGOTAMIN
Dihydroergotamin al
DIHYDROERGOTAMINE
DIHYDROERGOTAMINE MESILATE
Dihydroergotamine mesylate
Dihydroergotamine methanesulfonate
Dihydroergotamine monomethanesulfonate
Dihydroergotamine sandoz
Dihydroergotamine-sandoz
|
Dihydroergotaminum
Dihytamin
DIIDROERGOTAMINA
D-Tamin retard l.u.t.
Erganton
Ergomimet
Ergont
Ergotam von CT
Farmasan brand OF dihydroergotamine mesylate
Fujisawa brand OF dihydroergotamine mesylate
Hormosan brand OF dihydroergotamine mesylate
Ikaran
IPRAD brand OF dihydroergotamine mesylate
MAP0004
MAP-0004
Mesylate, dihydroergotamine
Methanesulfonate, dihydroergotamine
Migranal
Neomigran
Novartis brand OF dihydroergotamine mesylate
Orstanorm
Pharmafrid brand OF dihydroergotamine mesylate
Pierre fabre brand OF dihydroergotamine mesylate
Q Pharm brand OF dihydroergotamine mesylate
Q-Pharm brand OF dihydroergotamine mesylate
Ratiopharm brand OF dihydroergotamine mesylate
Sanol brand OF dihydroergotamine mesylate
Schwarz brand OF dihydroergotamine mesylate
Seglor
Shire brand OF dihydroergotamine mesylate
Tamik
TONOPAN
Verla brand OF dihydroergotamine mesylate
Verladyn
Von CT, ergotam
Wernigeroide brand OF dihydroergotamine mesylate
Xcel brand 1 OF dihydroergotamine mesylate
Xcel brand 2 OF dihydroergotamine mesylate
|
|
33 |
|
Clonidine |
Approved |
Phase 3 |
|
4205-91-8, 4205-90-7 |
2803 20179 |
Synonyms:
2-((2,6-Dichlorophenyl)imino)imidazolidine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2-[(2,6-Dichlorophenyl)imino]imidazoline
Adesipress
Boehringer ingelheim brand OF clonidine hydrochloride
Catapres
CATAPRES P.L.
CATAPRES TTS 1
CATAPRES TTS 2
CATAPRES TTS 3
Catapres®|Kapvay®
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Chlofazoline
Chlophazolin
Chlornidinum
Clofelin
Clofenil
Clonidin
Clonidina
Clonidine
Clonidine dihydrochloride
CLONIDINE HCL
Clonidine hydrochloride
|
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
CLORPRES
COMBIPRES
DICHLORANILINO IMIDAZOLIN
Dihydrochloride, clonidine
Dixarit
DURACLON
Duraclont
Gemiton
Hemiton
Hydrochloride, clonidine
Ipotensium
Isoglaucon
JENLOGA
KAPVAY
KAPVAY®
Klofelin
Klofenil
Monohydrobromide, clonidine
Monohydrochloride, clonidine
ST 155BS
ST-155
ST-155BS
ST-155-BS
Tenso-Timelets
|
|
34 |
|
Tizanidine |
Approved, Investigational |
Phase 3 |
|
51322-75-9 |
5487 |
Synonyms:
5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole
5-Chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole
5-Chloro-4-(2-imidazolin-4-on-2-ylamino)-2,1,3-benzothiadiazole
Acorda brand OF tizanidine hydrochloride
AN-021
DS-103-282
Novartis brand OF tizanidine hydrochloride
Sanofi synthelabo brand OF tizanidine hydrochloride
|
Sirdalud
Tizanidin
Tizanidina
Tizanidine
Tizanidine hydrochloride
Tizanidine monohydrochloride
Tizanidinum
Zanaflex
|
|
35 |
|
Candesartan |
Experimental |
Phase 2, Phase 3 |
|
139481-59-7 |
2541 |
Synonyms:
2-Ethoxy-1-(p-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate
2-Ethoxy-1-(p-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4Ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
Amias
Atacand
|
Blopress
Candesartan
Candesartan cilexetil
CANDESARTAN CILEXETIL RELATED COMPOUND G
CV-11974
CV-11974|TCV-116 (prodrug)
Ratacand
TCV-116 (PRODRUG)
|
|
36 |
|
Vasodilator Agents |
|
Phase 3 |
|
|
|
37 |
|
Central Nervous System Stimulants |
|
Phase 3 |
|
|
|
38 |
|
Phosphodiesterase Inhibitors |
|
Phase 3 |
|
|
|
39 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 3 |
|
|
|
40 |
|
Adrenergic beta-Antagonists |
|
Phase 2, Phase 3 |
|
|
|
41 |
|
Adrenergic Antagonists |
|
Phase 2, Phase 3 |
|
|
|
42 |
|
Anti-Arrhythmia Agents |
|
Phase 2, Phase 3 |
|
|
|
43 |
|
Angiotensinogen |
|
Phase 2, Phase 3 |
|
|
16133225 |
Synonyms:
Hypertensinogen
Proangiotensin
Renin substrate
Renin substrate tetradecapeptide
|
Renin-substrate
Serpin a8
SERPINA8
Tetradecapeptide, renin substrate
|
|
44 |
|
Angiotensin Receptor Antagonists |
|
Phase 2, Phase 3 |
|
|
|
45 |
|
Angiotensin II Type 1 Receptor Blockers |
|
Phase 2, Phase 3 |
|
|
|
46 |
|
Giapreza |
|
Phase 2, Phase 3 |
|
|
|
47 |
|
Anesthetics, Local |
|
Phase 3 |
|
|
|
48 |
|
Anesthetics |
|
Phase 3 |
|
|
|
49 |
|
Anti-Allergic Agents |
|
Phase 3 |
|
|
|
50 |
|
Histamine phosphate |
|
Phase 3 |
|
51-74-1 |
134614 |
Synonyms:
2)
4-(2-AMINOETHYL)IMIDAZOLE BIS(DIHYDROGEN PHOSPHATE)
4-(2-AMINOETHYL)IMIDAZOLE DI-ACID PHOSPHATE
HISTAMINE ACID PHOSPHATE
|
HISTAMINE BIPHOSPHATE
HISTAMINE DIHYDROGEN PHOSPHATE
HISTAMINE DIPHOSPHATE
HISTAMINE PHOSPHATE (1
|
|
Interventional clinical trials:
(show top 50)
(show all 84)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Open Label Study of Milnacipran in the Preventive Treatment of Episodic Migraine With and Without Aura and Chronic Migraine. |
Unknown status |
NCT01319825 |
Phase 4 |
milnacipran |
2 |
Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase. |
Completed |
NCT03689361 |
Phase 4 |
|
3 |
Efficacy of Combination Therapy With Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department |
Completed |
NCT01596166 |
Phase 4 |
Ketorolac Tromethamine;Metoclopramide |
4 |
TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study |
Completed |
NCT00212810 |
Phase 4 |
Topiramate |
5 |
Efficacy of AXERT (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy With TOPAMAX (Topiramate) |
Completed |
NCT00210496 |
Phase 4 |
topiramate; almotriptan malate |
6 |
A Randomized, Parallel-Group, Single-Attack, Open-Label Study to Evaluate the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (ATOM) |
Recruiting |
NCT05211154 |
Phase 4 |
Diclofenac Potassium 50Mg/Pkt Oral Pwdr;Rimegepant 75 MG |
7 |
A Randomized, Parallel-Group, Single-Attack, Open-Label Study to Evaluate the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine (ATOM). |
Recruiting |
NCT05214001 |
Phase 4 |
Almotriptan 12.5 Mg Oral Tablet;Ubrogepant 50Mg Tab |
8 |
Phase III Randomized Double-Blind Parallel Group Sham-Controlled Study Evaluating the Efficacy and Safety of Non-invasive Non-repetitive Transcranial Magnetic Stimulation (TMS) for the Acute Preemptive Treatment of the Aura Phase of Migraine Headache |
Completed |
NCT00449540 |
Phase 3 |
|
9 |
A Multicentre, Dose Optimisation Study to Assess the Consistency of Efficacy of Eletriptan for the Treatment of Migraine (With and Without Aura) |
Completed |
NCT01859481 |
Phase 3 |
Placebo;Eletriptan HBr 40 mg;Eletriptan HBr 80 mg |
10 |
Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache |
Completed |
NCT00471952 |
Phase 3 |
Maxalt 10mg MLT plus Caffeine 75mg;Maxalt 10mg MLT plus Placebo;Placebo + Placebo |
11 |
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine |
Completed |
NCT03901482 |
Phase 3 |
Dihydroergotamine;Placebos |
12 |
Candesartan vs Propranolol for Migraine Prevention: A Double Blind, Placebo Controlled, Double Dummy, Triple Cross-over Study |
Completed |
NCT00884663 |
Phase 2, Phase 3 |
Candesartan;propranolol;placebo |
13 |
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine |
Completed |
NCT04940390 |
Phase 3 |
Dihydroergotamine;Placebo |
14 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine |
Completed |
NCT00231595 |
Phase 3 |
topiramate |
15 |
A Multi-Center, Randomized, Parallel, Double-Blind, Placebo-Controlled Study in Evaluation the Efficacy and Safety of Laxymig® ER as Prophylactic Treatment in Patients With Migraine |
Completed |
NCT00334178 |
Phase 3 |
Laxymig ER (drug) |
16 |
A Randomized, Double-Blind, Parallel-Group, Dose-Response Study to Evaluate the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prophylaxis of Migraine |
Completed |
NCT00236561 |
Phase 3 |
topiramate, propranolol |
17 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine |
Completed |
NCT00236509 |
Phase 3 |
topiramate |
18 |
A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine |
Completed |
NCT00131443 |
Phase 2, Phase 3 |
Topiramate |
19 |
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment: a Randomized, Double Blind Clinical Trial |
Completed |
NCT01814189 |
Phase 3 |
Sumatriptan+Promethazine (SPr) |
20 |
Randomized Double Blinded Monocentric Study Evaluating the Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room |
Recruiting |
NCT04726592 |
Phase 3 |
Clorazepate Dipotassium;Placebo;Ketoprofen;Metoclopramide |
21 |
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine |
Active, not recruiting |
NCT04406649 |
Phase 3 |
Dihydroergotamine |
22 |
Safety and Efficacy of Oral Tizanidine Hydrochloride in Preventing Migraine Attacks in Adult Migraine Patients: a Multicenter, Randomized, Double Blind, Placebo Controlled Clinical Study |
Not yet recruiting |
NCT05484349 |
Phase 3 |
Tizanidine Hydrochloride;Tizanidine Hydrochloride Placebo |
23 |
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study To Evaluate The Efficacy, Safety, And Tolerability Of Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine |
Not yet recruiting |
NCT05416476 |
Phase 3 |
Anisodine Hydrobromide;Anisodine Hydrobromide placebo |
24 |
Safety and Efficacy of De-Novo Algorithm and Formula in the Treatment of Patients With Intractable Chronic Craniofacial Neuralgia, or Chronic Migraine Headaches. |
Unknown status |
NCT03220113 |
Phase 1, Phase 2 |
|
25 |
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura |
Unknown status |
NCT04063540 |
Phase 2 |
Amiloride;Placebos |
26 |
A Phase 2a Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura |
Unknown status |
NCT00877838 |
Phase 2 |
NXN-188;Placebo |
27 |
Intranasal AST-726 Treatment for Prophylaxis of Migraine: A Placebo-Controlled Clinical Study |
Unknown status |
NCT00285402 |
Phase 2 |
AST-726 Low dose;AST-726 High dose;AST-726 Placebo |
28 |
Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled, Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache and Open Label Extension |
Completed |
NCT00534560 |
Phase 2 |
Tonabersat;Placebo |
29 |
A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache |
Completed |
NCT00123201 |
Phase 2 |
Dronabinol MDI |
30 |
A Phase 2 Study of the Safety and Effectiveness of a Single Oral Dose of NXN 188 for the Treatment of Moderate to Severe Migraine Headache With Aura |
Completed |
NCT00920686 |
Phase 2 |
NXN-188;placebo;sumatriptan succinate |
31 |
A Single Centre, Double-blind, Randomised, Placebo Controlled Crossover Study to Evaluate the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine in Patients Presenting With Migraine With Aura |
Completed |
NCT00332007 |
Phase 2 |
Tonabersat;Placebo |
32 |
Multi-centre, Parallel Group, Double-blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache |
Completed |
NCT00311662 |
Phase 2 |
Tonabersat;Placebo |
33 |
An Open-Label Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine |
Completed |
NCT00158002 |
Phase 2 |
Topiramate |
34 |
Effects of DFN-15 on Migraine With Allodynia |
Completed |
NCT03472378 |
Phase 2 |
DFN-15 |
35 |
A Randomized, Double-blind Placebo-controlled, Parallel Group Study to Study the Efficacy and Tolerability of Ramelteon (Rozerem) in the Prophylaxis of Migraine |
Terminated |
NCT00739024 |
Phase 2 |
Ramelteon;Placebo |
36 |
Percutaneous Closure of Patent Foramen Ovale In Migraine With Aura - A Randomized Prospective Study (Prima Trial) |
Terminated |
NCT00505570 |
Phase 2 |
|
37 |
A Randomized, Open-Label, Crossover Study to Evaluate the PK, Bioavailability, Dose Proportionality, Safety, and Tolerability of Single Doses of STS101, DHE Mesylate IM Injection and DHE Mesylate Nasal Spray in Healthy Adult Subjects |
Completed |
NCT03874832 |
Phase 1 |
Dihydroergotamine |
38 |
A Randomized, Open-Label, 5-Period Crossover Study to Evaluate the PK, Bioavailability, Safety, and Tolerability of Single Doses of STS101, DHE IM Injection and DHE Nasal Spray in Healthy Adult Subjects |
Completed |
NCT05337254 |
Phase 1 |
Dihydroergotamine |
39 |
MR-Angiografi (MRA) og MR-Spektroskopi (MRS) Hos Raske forsøgspersoner og Patienter Med migræne Uden Aura Provokeret Med Calcitonin Gen-relateret Peptid (CGRP) og Sildenafil |
Unknown status |
NCT03143465 |
|
Calcitonin Gene-Related Peptide;Sildenafil;Placebo |
40 |
A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura |
Unknown status |
NCT00893594 |
|
sumatriptan with naprosyn;placebo |
41 |
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients |
Unknown status |
NCT04452929 |
|
Erenumab;Placebo;Calcitonin gene-related peptide;Cilostazol |
42 |
Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI |
Unknown status |
NCT02202486 |
|
|
43 |
Functional MRI and MRA in Migraine With Aura |
Unknown status |
NCT01388894 |
|
|
44 |
Investigations of the Endogenous Vasoconstrictor and Neuromodulator Peptide Endothelin-1 as a Potential Trigger of Migraine Aura |
Unknown status |
NCT02906085 |
|
Endothelin-1;Placebo |
45 |
CGRP-induced Headache in Patients With Familial Hemiplegic Migraine, Migraine With Aura and Healthy Controls |
Completed |
NCT00687947 |
|
CGRP |
46 |
Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura : a MRI and Transcranial Doppler. |
Completed |
NCT02708797 |
|
|
47 |
Impact of tDCS on Cerebral Autoregulation |
Completed |
NCT01865604 |
|
|
48 |
IndoProCaf (Difmetre®) Effervescent Tablets Effectiveness in Acute Treatment of Primary Headaches (Migraine and/or Episodic Tension-type Headache) and Patients' Satisfaction With the Treatment in Routine Clinical Practice in Ukraine and Kazakhstan |
Completed |
NCT02115269 |
|
|
49 |
Women With Migraine With Aura Neuroimaging (WOMAN) Study: A Population-based Study of Danish Twins |
Completed |
NCT02047695 |
|
|
50 |
Study of Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries by Hypoxia in a Humane Experimental Migraine Model |
Completed |
NCT01896167 |
|
|
|